Kite Pharmaceuticals, Inc.
Nov 4, 2015

Kite Pharma to Present at Upcoming Investor Conferences in November 2015

SANTA MONICA, Calif., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present at several upcoming investor conferences this month:

Date: Tuesday, November 10, 2015
Time: 10:30am Mountain Time
Location: Phoenix, AZ

Date: Tuesday, November 17, 2015
Time: 11:45am Eastern Time
Location: New York, NY

Date: Wednesday, November 18, 2015
Time: 10:00am Greenwich Mean Time
Location: London, UK

Date: Thursday, November 19, 2015
Time: 3:10pm Eastern Time
Location: New York, NY

Kite's corporate overview to be presented at each of the conferences will be available through the Calendar of Events section of Kite's website at ir.kitepharma.com. The presentations from the Jefferies London Healthcare Conference and the Goldman Sachs US Emerging/SMID Cap Growth Conference will be webcasted and will be available along with the corporate overview to be presented at each of the November conferences through the Calendar of Events section of Kite's website at ir.kitepharma.com.

About Kite Pharma, Inc.

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

CONTACT: Kite Pharma:

         Cynthia M. Butitta, Chief Financial Officer

         and Chief Operating Officer

         310-824-9999

         

         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns

         Burns McClellan

         212-213-0006

         jjackson@burnsmc.com

         lburns@burnsmc.com